Systems level analysis and identification of pathways and networks associated with liver fibrosis.
No Thumbnail Available
Date
2014-11-08
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Toxic liver injury causes necrosis and fibrosis which may lead to cirrhosis and liver failure Despite recent progress in understanding the mechanism of liver fibrosis our knowledge of the molecular level details of this disease is still incomplete The elucidation of networks and pathways associated with liver fibrosis can provide insight into the underlying molecular mechanisms of the disease as well as identify potential diagnostic or prognostic biomarkers Towards this end we analyzed rat gene expression data from a range of chemical exposures that produced observable periportal liver fibrosis as documented in DrugMatrix a publicly available toxicogenomics database We identified genes relevant to liver fibrosis using standard differential expression and co expression analyses and then used these genes in pathway enrichment and protein protein interaction PPI network analyses We identified a PPI network module associated with liver fibrosis that includes known liver fibrosis relevant genes such as tissue inhibitor of metalloproteinase 1 galectin 3 connective tissue growth factor and lipocalin 2 We also identified several new genes such as perilipin 3 legumain and myocilin which were associated with liver fibrosis We further analyzed the expression pattern of the genes in the PPI network module across a wide range of 640 chemical exposure conditions in DrugMatrix and identified early indications of liver fibrosis for carbon tetrachloride and lipopolysaccharide exposures Although it is well known that carbon tetrachloride and lipopolysaccharide can cause liver fibrosis our network analysis was able to link these compounds to potential fibrotic damage before histopathological changes associated with liver fibrosis appeared These results demonstrated that our approach is capable of identifying early stage indicators of liver fibrosis and underscore its potential to aid in predictive toxicity biomarker identification and to generally identify disease relevant pathways